Trials / Withdrawn
WithdrawnNCT01582685
Exercise in Breast Cancer Survivors
Exercise in Breast Cancer Survivors: Analysis of Angiogenic Profile
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Mississippi Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that exercise in postmenopausal breast cancer survivors will result in an increase in the plasma concentrations of angiostatic factors and a decrease in the plasma concentrations of angiogenic factors. Exercise is expected to result in a circulating angiostatic phenotype that inhibits adipose tissue mass, growth of breast cancer tumor, growth of microscopic residual disease after breast cancer resection, decreases rates of local-regional recurrence, decreases rates of distant recurrence, and increases survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise | The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks. |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2012-04-23
- Last updated
- 2014-12-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01582685. Inclusion in this directory is not an endorsement.